Polyclonal Activation of B Cells by Lactate Dehydrogenase-Elevating Virus is Mediated by N-Glycans on the Short Ectodomain of the Primary Envelope Glycoprotein

  • Peter G. W. Plagemann
  • Quentin A. Jones
  • William A. Cafruny
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 494)


The common strains of lactate dehydrogenase-elevating virus (LDV-P and LD-vx) are primary examples for viruses that cause a permanent polyclonal activation of B cells that results in IgG2a hyper-gammaglobulinemia and the generation of autoantibodies and circulating immune complexes in their host, the mouse (Notkins et al., 1966; Coutelier and van Snick, 1985; Li et al, 1990). Plasma IgG2a levels increase from generally below 0.5 mg/ml to 2-6 mg/ml by two weeks post infection (p.i.) and remain elevated thereafter (see later). LDV-P/vx cause life-long persistent viremic infections (see Fig. 1A) which are maintained by continuous rounds of replication in a renewable subpopulation of macrophages and resistance to host immune responses (Plagemann, 1996). Previous results have shown that the single neutralization epitope located on the short (about 30 amino acids long) ectodomain of the primary envelope glycoprotein, VP-3P, carries three large N-glycan chains in LDV-P and LDV-vx (see Fig. 1A insert) that suppress the immunogenicity of the epitope and impair antibody neutralization of the virions of these quasispecies (Chen et al, 2000; Plagemann et al., 1999). The present results indicate that the three N-glycans on the VP-3P ectodomains of LDV-P/vx also play a critical role in the polyclonal activation of B cells by these LDVs.


Immune Complex Infected Mouse Antiviral Immune Response Immune Complex Formation Polyclonal Activation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Ahmed, R., and Oldstone, M. B. A., 1984, Mechanisms and biological implications of virus-induced B-cell activation. In Concepts in Viral Pathogenesis (A. L. Notkins and M. B. A. Oldstone. eds.), Springer Verlag. New York, pp. 231–238.CrossRefGoogle Scholar
  2. Cafruny, W. A., Heruth, D. P., Jaqua, M. J., and Plagemann, P. G. W., 1986, Immunoglobulins that bind to uncoated ELISA plates: appearance in mice during infection with lactate dehydrogenase-elevating virus and in human anti-nuclear antibody positive sera. J. Med. Virol. 19:175–186.PubMedCrossRefGoogle Scholar
  3. Chen, Z., Li, K., and Plagemann, P. G. W., 2000, Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. Virology. 266:88–98.PubMedCrossRefGoogle Scholar
  4. Chen, Z., Li, K., Rowland, R. R. R., Anderson, G. W., and Plagemann, P. G. W., 1998, Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired ability for high viremic persistent infection. J. Neurovirol. 4:560–568.PubMedCrossRefGoogle Scholar
  5. Coutelier, J.-P., Coulie, P. G., Wauters, P., Heremans, H., and van der Logt, J. T. M., 1990, In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J. Virology. 64:5383–5388.PubMedGoogle Scholar
  6. Coutelier, J.-P., and van Snick, J., 1985, Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur. J. Immunol. 15:250–255.PubMedCrossRefGoogle Scholar
  7. Faaberg, K. S., and Plagemann, P. G. W., 1995, The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Virology 212:512–525.PubMedCrossRefGoogle Scholar
  8. Faaberg, K. S., and Plagemann, P. G. W., 1997, ORF3 of lactate dehydrogenase-elevating virus encodes a soluble, nonstructural, highly glycosylated, and antigenic protein. Virology 227:245–251.PubMedCrossRefGoogle Scholar
  9. Hu, B., Even, C., and Plagemann, P. G. W., 1992, Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: Relationship to IgG2a and IgG2b-specific polyclonal activation of B cells. Viral Immunol 5:27–38.PubMedCrossRefGoogle Scholar
  10. Janeway, C. A., Travers, P., Walport, M., and Capra, J. D., 1999, Immunobiology. 4th edn., pp. 3231–3323. Garland Publishing.Google Scholar
  11. Li, K., Chen, Z., and Plagemann, P. G. W., 1999, High frequency genetic recombination of an arterivirus, lactate dehydrogenase-elevating virus, in mice and evolution of neuropathogenic variants. Virology 258:73–83.PubMedCrossRefGoogle Scholar
  12. Li, K., Schuler, T., Chen, Z., Glass, G. E. G., Childs, J. E., and Plagemann, P. G. W., 2000, Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization. Virus. Res., In press.Google Scholar
  13. Li, X., Hu, B., Harty, J. T., Even, C., and Plagemann, P. G. W., 1990, Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes. Viral. Immunol. 3:273–288.PubMedCrossRefGoogle Scholar
  14. Notkins, A. L., Mergenhagen, S. E., Rizzo, A. A., Scheele, C., and Waldmann, T. A., 1966, Elevated y globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J. Exper. Med. 123:347–356.CrossRefGoogle Scholar
  15. Plagemann, P. G. W., 1996, Lactate dehydrogenase-elevating virus and related viruses. In Virology, 3rd edn, (B. N. Fields, D. M. Knipe, & P. M. Howley, eds) Raven Press, New York, pp. 1105–1120.Google Scholar
  16. Plagemann, P. G. W., Chen, Z., and Li., K., 1999, Polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein of an arterivirus determine its neuropathogenicity, sensitivity to antibody neutralization and immunogenicity of the neutralization epitope. Curr.Top. Virol. 1:27–43.Google Scholar
  17. Plagemann, P. G. W., Rowland, R. R. R., Even, C., and Faaberg, K. S., 1995, Lactate dehydrogenase-elevating virus— an ideal persistent virus? Seminars in Immunopathobiol. 17:167–186.Google Scholar
  18. Rowland, R. R. R., Even, C., Anderson, G. W., Chen, Z., Hu, B., and Plagemann, P. G. W., 1994, Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viremia or the polyclonal activation of B cells and immune complex formation. J. Gen. Virol. 75:1071–1081.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Peter G. W. Plagemann
    • 1
  • Quentin A. Jones
    • 2
  • William A. Cafruny
    • 2
  1. 1.Department of MicrobiologyUniversity of MinnesotaMinneapolisUSA
  2. 2.Division of Basic Biomedical Sciences, Molecular Microbiology & Immunology GroupUniversity of Soutl Dakota School of MedicineVermillionUSA

Personalised recommendations